000			01364 a2200397 4500
005			20250514221836.0
264		0	_c20050517
008			200505s 0 0 eng d
022			_a0277-0008
024	7		_a10.1592/phco.25.2.244.56943 _2doi
040			_aNLM _beng _cNLM
100	1		_aStout, Dena L
245	0	0	_aThiazolidinediones for treatment of polycystic ovary syndrome. _h[electronic resource]
260			_bPharmacotherapy _cFeb 2005
300			_a244-52 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAdult
650	0	4	_aChromans _xadverse effects
650	0	4	_aClinical Trials as Topic
650	0	4	_aClomiphene _xtherapeutic use
650	0	4	_aContraceptives, Oral _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFertility Agents, Female _xtherapeutic use
650	0	4	_aHumans
650	0	4	_aHypoglycemic Agents _xadverse effects
650	0	4	_aMetformin _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aOvulation _xdrug effects
650	0	4	_aPioglitazone
650	0	4	_aPolycystic Ovary Syndrome _xdrug therapy
650	0	4	_aThiazolidinediones _xadverse effects
650	0	4	_aTroglitazone
700	1		_aFugate, Susan E
773	0		_tPharmacotherapy _gvol. 25 _gno. 2 _gp. 244-52
856	4	0	_uhttps://doi.org/10.1592/phco.25.2.244.56943 _zAvailable from publisher's website
999			_c15439961 _d15439961